Replies to post #214494 on Biotech Values

[semi_infinite]

wrt FXR valuation, ICPT had peaked close to 6.7B EV as of May 2015 10Q compared to the current ~1.5B. What should it be for something that works and where do you place enta's probability of success?

[Bickema]

Do you expect a partner for EDP 305 to get involved before phase 2 trial design and recruitment?